Karen Williamson
- Co-authors
- Jean‐Michel DayerP SeckingerA CruchaudJean-François BalavoineWilliam G. RiceMark A. PaytonPaul T. WingfieldAlan Shaw
- Topics
- HIV Research and Treatment (6 papers)HIV/AIDS drug development and treatment (6 papers)Antiplatelet Therapy and Cardiovascular Diseases (2 papers)
- Journals
- Journal of Clinical InvestigationJournal of Medicinal ChemistryAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesSwitzerlandBelgium
In The Last Decade
Karen Williamson
10 papers receiving 515 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 186
- Immunology 180
- Infectious Diseases 124
- Virology 94
- Organic Chemistry 84
Countries citing papers authored by Karen Williamson
This map shows the geographic impact of Karen Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Williamson more than expected).
Fields of papers citing papers by Karen Williamson
This network shows the impact of papers produced by Karen Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Williamson. The network helps show where Karen Williamson may publish in the future.
Co-authorship network of co-authors of Karen Williamson
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Williamson. A scholar is included among the top collaborators of Karen Williamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Williamson. Karen Williamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 77 | |
| 3 | 16 | |
| 4 | 30 | |
| 5 | 44 | |
| 6 | 3 | |
| 7 | 167 | |
| 8 | 144 | |
| 9 | 37 | |
| 10 | Antithrombotic actions and pharmacokinetics of heparin fractions and fragments. | 12 |
About Karen Williamson
Karen Williamson is a scholar working on Virology, Infectious Diseases and Immunology, having authored 10 papers that have together received 544 indexed citations. Recurring topics across this work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). The work is most often cited by research in Virology (94 citations), Immunology (180 citations) and Infectious Diseases (124 citations). Karen Williamson has collaborated with scholars based in United States, Switzerland and Belgium. Frequent co-authors include Jean‐Michel Dayer, P Seckinger, A Cruchaud, Jean-François Balavoine, William G. Rice, Mark A. Payton, Paul T. Wingfield, Alan Shaw, M G Simona and Keith Rose. Their work appears in journals such as Journal of Clinical Investigation, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.